Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

23 Mar 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated March 23, 2016, titled ‘Glenmark Pharmaceuticals receives ANDA approval for Raloxifene Hydrochloride Tablets USP, 60 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..